Medical staff from Yonsei University Health System (YUHS) and Korean robotics firm Curexo signed a memorandum of understanding (MOU) Monday to develop a next-generational surgical robot.
|Yoon Do-heum (left), president and CEO of the Yonsei University Health System, shakes hands with Curexo CEO Lee Jae-jun, after signing an MOU to foster development of surgical robots.|
The two organizations will cooperate in the field of research and development and introduce medical robots in a variety of areas including that of neurosurgery and rehabilitation medicine, YUHS said.
“We look forward to developing a good product that will help patients by pooling the strength of Curexo, a firm specializing in medical robots, and Severance, which leads the field of robotic surgery in Korea,” said Yoon Do-heum, president, and CEO of YUHS.
Severance is leading the robotic surgical field in Korea, YUHS said, adding that it has completed 19,000 cases of robotic surgeries since first implementing robots in 2005. The hospital stressed it has been pursuing various partnerships to develop robotic surgeries.
Lee Jae-jun, the CEO and representative director of Curexo, noted that the two organizations would work to develop a surgical robot that patients want, expecting that it would generate a more attractive product by working with YUHS.
Curexo is a Korean company that develops and provides medical equipment that has Hyundai Heavy Industries and Korea Yakult Corporation as its largest shareholders. The company entered into an exclusive cross-selling distribution agreement with Canada’s Bionik earlier this month, YUHS said.
Through the agreement, Bionik obtained exclusive rights to sell Curexo's Morning Walk lower body rehabilitation technology in the U.S. while Curexo gained exclusive rights to sell Bionik's robotic products in Korea. Curexo also said it signed a strategic partnership agreement with Zimmer Biomet Asia to sell its artificial joint surgery robots exclusively in Japan and Australia.